资讯
CAR-T therapy targeting TM4SF1 in aggressive bladder cancer (HV) histologic variant , offering hope for treatment-resistant ...
EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...
6 天
AZoNano on MSNNovel Nanoplatform Overcomes Treatment Resistance in Bladder CancerA breakthrough in bladder cancer treatment at the University of California, Davis: multifunctional nanoparticles enhance ...
26 天on MSN
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...
Bengaluru: Incidenceof bladder cancer in India is steadily rising, Dr Niti Raizada, a renowned oncologist in Bengaluru, has ...
7 天
News-Medical.Net on MSNBreakthrough therapy targets aggressive bladder cancer variantBladder tumors that have been excluded from clinical trials have a few things in common that could lead to new therapies.
The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing ...
Despite a recent rebuff from an FDA advisory committee, the first treatment for a specific and underserved cohort of U.S. | ...
“Pelvic floor therapy is like physical therapy to strengthen all the muscles and tissues in your pelvis that can become weak ...
Scientists found a way to identify and possibly treat a mysterious type of bladder cancer that affects up to 1 in 4 cases.
At ASCO 2025, ImmunityBio’s chief medical officer, Dr Sandeep Reddy, spoke with pharmaphorum about the importance of FDA ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果